Gyrolab Generic TK Kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems Uppsala, Sweden, 16 January 2018: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic (TK) studies. The... Read more
As President, Dawn Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth at Luna DNA. SAN DIEGO, Jan. 15, 2018 /PRNewswire/ — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced today Dawn Barry as president. In... Read more
The latest version of Sapientia™, v1.7, is to be released today (15th January 2018) bringing with it an array of infrastructure improvements, alongside three key new features: a simple and practical ACMG Guidelines interface, improved gene panel management and the first look at the automated interpretation request template. Version 1.7 is underpinned by a significant... Read more
Thermo Fisher Scientific Designs Flexible Manufacturing Site for Flexion Therapeutics, Inc. DURHAM, N.C., Jan. 11, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, announced today that manufacturing of Zilretta™, is underway at its Swindon, U.K. site where a custom “condo” manufacturing suite has been installed to support the launch of Flexion’s... Read more
January 09, 2018 06:00 AM Pacific Standard Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys (2PG) announced today that it is collaborating with Maxim Integrated Products, Inc. (NASDAQ: MXIM), on a series of analog signal processing technologies for 2PG’s solid-state nanopore diagnostic testing platform. As part of this collaboration, Maxim has invested in 2PG through its... Read more
–Collaboration will be a new service offering for Berry Genomics and entry point for 10x Genomics into the NIPT Market in China– PLEASANTON, CA. and BEIJING, CHINA —January 8, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, and Berry Genomics Co. Ltd (SZSE:000710), a company devoted to developing and offering genomic solutions for... Read more
Thermo Fisher Scientific Expands Oncomine Portfolio for Liquid Biopsy and Immuno-oncology Clinical Research New pan-cancer cell-free total nucleic acid (cfTNA) assay and FFPE-based tumor mutation load analysis assay, coupled with novel Ion AmpliSeq HD technology, extend industry-leading Oncomine menu and enable panel design customization CARLSBAD, Calif., Jan. 8, 2018 /PRNewswire/ — Thermo Fisher Scientific has expanded... Read more
Basel, 08 January 2018 Roche and GE enter partnership to develop integrated digital diagnostics platform to improve oncology and critical care treatment Companies aim to develop jointly-branded clinical decision support software for faster, more accurate, more confident decision-making, enabling earlier diagnosis and individualised treatment Partnership will apply advanced analytics to in-vivo data from GE’s medical... Read more
Chicago, USA Jan 8, 2018 – GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointly develop and co-market digital clinical decision support solutions. The partnership will initially focus on products that accelerate and improve individualized treatment options for cancer and critical care patients. The two companies... Read more
Basel, 08 January 2018 Roche and GE enter partnership to develop integrated digital diagnostics platform to improve oncology and critical care treatment Companies aim to develop jointly-branded clinical decision support software for faster, more accurate, more confident decision-making, enabling earlier diagnosis and individualised treatment Partnership will apply advanced analytics to in-vivo data from GE’s medical... Read more